Pregled bibliografske jedinice broj: 607063
6-(3, 4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor
6-(3, 4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor // Journal of medicinal chemistry, 53 (2010), 13; 4989-5001 doi:10.1021/jm100481d (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 607063 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
6-(3, 4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor
Autori
Micheli, Fabrizio ; Cavanni, Paolo ; Andreotti, Daniele ; Arban, Roberto ; Benedetti, Roberto ; Bertani, Barbara ; Bettati, Michela ; Bettelini, Letizia ; Bonanomi, Giorgio ; Braggio, Simone ; Carletti, Renzo ; Checchia, Anna ; Corsi, Mauro ; Fazzolari, Elettra ; Fontana, Stefano ; Marchioro, Carla ; Merlo-Pich, Emilio ; Negri, Michele ; Oliosi, Beatrice ; Ratti, Emiliangelo ; Read, Kevin D. ; Roščić, Maja ; Sartori, Ilaria ; Spada, Simone ; Tedesco, Giovanna ; Tarsi, Luca ; Terreni, Silvia ; Visentini, Filippo ; Zocchi, Alessandro ; Zonzini, Laura ; Di Fabio, Romano
Izvornik
Journal of medicinal chemistry (0022-2623) 53
(2010), 13;
4989-5001
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
CNS; depression; triple reuptake inhibitors; TRUI; monoamine transporters
Sažetak
A pharmacophore model for triple reuptake inhibitors and the new class of 1-(aryl)-6-[alkoxyalkyl]-3- azabicyclo[3.1.0]hexanes were recently reported. Further investigation in this area led to the identification of a new series of potent and selective triple reuptake inhibitors endowed with good developability characteristics. Excellent bioavailability and brain penetration are associated with this series of 6-(3, 4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptanes together with high in vitro potency and selectivity at SERT, NET, and DAT. In vivo microdialysis experiments in different animal models and receptor occupancy studies in rat confirmed that derivative 17 showed an appropriate profile to guarantee further progression of the compound.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE